CBLL
NASDAQ HealthcareCeriBell, Inc. - Common Stock
Medical Devices
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
๐ Market Data
| Price | $24.40 |
|---|---|
| Volume | 396,318 |
| Market Cap | 936.43M |
| RSI (14-Day) | 90.2 Overbought |
| 200-Day MA | $18.86 |
| 50-Day MA | $18.98 |
| 52-Week High | $24.43 |
| 52-Week Low | $10.85 |
| Forward P/E | -15.87 |
| Price / Book | 7.27 |
๐ฏ Investment Strategy Scores
CBLL scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (99/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ช Falling Knife (3/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find CBLL in your text
Paste any article, transcript, or post โ the tool will extract CBLL and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.